DEPTOR and ovarian carcinoma: Moreover, DEPTOR has been shown to be downregulated in malignancies of the prostate, bladder, head and neck, cervix and thyroid (14), whereas we have previously demonstrated the significant upregulation of DEPTOR in two paclitaxel-resistant ovarian cancer cell lines when compared to the parental ones (16).